Cardiovascular disease is the leading cause of death worldwide. Dysregulation of microRNAs (miRNAs) has been found to be associated with cardiovascular diseases such as atherosclerosis. In the present study, we examined the role of miR-147b in the proliferation and migration of vascular smooth muscle cells (VSMCs). Quantitative real-time PCR was performed to determine the expression levels of miR-147b and Yin Yang 1 (YY1) mRNA. CCK-8, transwell migration and wound healing assays were used to determine cell proliferation and migration of VSMCs, respectively. Luciferase reporter assay confirmed the downstream target of miR-147b. The protein level of YY1 was measured by western blot analysis. Platelet-derived growth factor-bb (PDGF-bb) treatment promoted cell proliferation and increased miR-147b expression in VSMCs. Overexpression of miR-147b enhanced cell proliferation and migration of VSMCs, while knock-down of miR-147b suppressed cell proliferation and migration of VSMCs or PDGF-bb-treated VSMCs. Further, bioinformatics prediction and luciferase reporter assay showed that YY1 was a downstream target of miR-147b, and miR-147b negatively regulated the mRNA and protein expression of YY1 in VSMCs. Overexpression of YY1 inhibited cell proliferation and migration of VSMCs and attenuated the effects of miR-147b overexpression on cell proliferation and migration. In addition, overexpression of miR-147b increased the Wnt/β-catenin signaling activities in VSMCs. In conclusion, our results suggest that miR-147b plays important roles in the control of cell proliferation and migration of VSMCs possibly via targeting YY1.
Introduction
Cardiovascular disease is the leading cause of death worldwide [1] . Atherosclerosis is one of the most common causes of cardiovascular disease [2] . VSMCs are the main cell type in blood vessel walls, where they play an important role in regulating the normal physiological function of blood vessels [3] . A growing evidence has shown that the structure and function of vascular smooth muscle cells (VSMCs) in atherosclerotic plaques are dynamically changed in the different states of atherosclerosis, and studies have also revealed that aberrant proliferation and migration of VSMCs play important roles in the pathogenesis of atherosclerosis [4] . Unfortunately, the exact pathogenesis of atherosclerosis is largely unknown. In this regard, understanding the key regulators and signaling pathways in the regulation of VSMC proliferation and migration may provide us with new strategies to control the progression of atherosclerosis.
MicroRNAs (miRNAs) are a class of short (~22 nt) non-coding endogenous RNAs, and regulate gene expression at the posttranscription level via targeting the 3′ untranslated regions (3′UTR) of specific mRNAs, which results in the regulation of many cellular processes including cell proliferation, cell migration, cell differentiation and cell apoptosis [5] [6] [7] . Various miRNAs have been demonstrated to play functional roles in the pathogenesis of cardiovascular diseases including atherosclerosis. For instances, inhibition of miR-208b improves the cardiac function in titin-based dilated cardiomyopathy [8] ; miR-19b is a potential biomarker of increased myocardial collagen cross-linking in patients with aortic stenosis and heart failure [9] ; miR-155 was found to regulate high glucose-induced cardiac fibrosis via the tumor growth factor-β signaling pathway [10] . In the aspects of atherosclerosis, a handful of miRNAs, such as miR-150, miR-365 and miR29a, were found to play functional roles in the pathogenesis of atherosclerosis [11] [12] [13] . MiR-147b is located in the chromosome 15q21.1, and it has been found that miR-147b plays oncogenic role in hepatocellular carcinoma [14] . In addition, miR-147b was found to have similar functional activity with miR-201, which was found to be involved in the pathogenesis of heart failure [15] . Recently, miR-147b was found to be up-regulated in the patients with atherosclerosis [16] . However, the molecular mechanisms of miR-147b in the pathogenesis of atherosclerosis have not been studied yet.
Ying Yang 1 (YY1), also known as NF-E1, UCRBP and CF1, was first identified as a ubiquitous and dual-function GLI-Kruppel zinc finger transcription factor and was found to negatively regulate the adeno-associated virus P5 promoter [17] . Recently, studies have shown that YY1 had inhibitory effects on the cell proliferation of muscle cells. YY1 was found to inhibit VSMCs cell growth by repressing p21WAF1/Clip1 transcription and p21WAF1/Clip1Cdk4-cyclin D1 assembly [18] . YY1 also inhibited VSMCs differentiation, and was targeted by miR-29a in VSMCs [19] . Whether YY1 is regulated by miR-147b and regulates cell proliferation of VSMCs is largely unknown.
In the present study, we firstly investigated the impact of pathogenic stimuli on the expression levels of miR-147b in VSMCs. The gain-/loss-of-function studies were performed to investigate the underlying mechanisms of miR-147b in the proliferation and migration of VSMCs. In addition, the downstream targets and relative signaling pathways regulated by miR-147b were also explored. The present study will provide novel insights into understanding the roles of miR-147b in regulating the biological behaviors of VSMCs.
Materials and Methods

Cell culture
Human aortic VSMCs were obtained from Sciencell (Carlsbad, USA) and were cultured in the Dulbecco's modified Eagle's medium (DMEM; Gibco, Waltham, USA) supplemented with 10% fetal bovine serum (FBS; Gibco). Cells were kept in a humidified incubator with 5% CO 2 at 37°C. All the cells used in the present study were between passages 5 and 6.
Cell treatment
The pathogenic stimuli were achieved by treating the VSMCs with 20 ng/ml platelet-derived growth factor (PDGF-bb; Sigma, St. Louis, USA). Briefly, VSMCs were serum-starved for 24 h, and then VSMCs were treated with 20 ng/ml PDGF-bb. At 0, 12, 24 and 48 h after the treatment, VSMCs were collected for further experimentation.
MiRNA mimics and inhibitors, small interfering RNAs, plasmids and transfection
The miR-147b mimics and inhibitors as well as their respective scrambled miRNAs were synthesized by RiboBio (Guangzhou, China), and the small interfering RNA (siRNA) for YY1 (si-YY1) and the negative control siRNA (si-NC) were also designed and synthesized by RiboBio. The YY1 overexpressing plasmid (pcDNA3.1-YY1) and the negative control (pcDNA3.1) were purchased from the GenePharma (Shanghai, China). The sequences are listed in Table 1 . VSMCs transfection with miRNAs, siRNAs and plasmids were performed by using Lipofectamine 2000 reagent (Invitrogen, Carlsbad, USA) according to the manufacturer's instruction. At 24 h post-transfection, transfected VSMCs were then processed for further experimentation.
Quantitative real-time PCR
The mRNAs and miRNAs in VSMCs were extracted by using TRIzol reagent (Invitrogen) according to the manufacturer's instruction. The mRNA and miRNA were reversely transcribed into cDNA by using the PrimeScript RT Kit (TaKaRa, Dalian, China) and One
Step PrimeScript miRNA synthesis Kit (TaKaRa). Real-time PCR was performed on the ABI 7300 real-time PCR system (Applied Biosystems, Waltham, USA) with the SYBR Green method according to the manufacturer's instruction (TaKaRa). GAPDH and U6 were used as internal control for mRNAs and miR-147b, 
respectively, and the relative expression levels of miR-147b and mRNAs were calculated based on the comparative Ct method. The sequence for the primers was shown in Table 2 .
CCK-8 assay
VSMCs were treated with 20 ng/ml PDGF-bb, or the VSMCs were transfected with miRNAs (mimics control, miR-147b mimics, inhibitor control, or miR-147b inhibitors), plasmids (pcDNA3.1 or pcDNA3.1-YY1) or siRNAs (si-NC or si-YY1), or VSMCs were first treated with 20 ng/ml PDGF-bb for 24 h and then transfected with miR-147b inhibitors or inhibitor control, or the VSMCs were cotransfected with miRNAs + plasmids, then the treated cells were subject to CCK-8 assay. For the CCK-8 assay, the treated VSMCs were seeded into 96-well plates and cultured for 48 h. Then, the supernatant was removed and CCK-8 solution (Beyotime, Beijing, China) was added to each well and further incubated for 2 h at 37°C. The OD values at the wavelength of 450 nm were then detected using a microplate reader (Thermo Fisher Scientific, Waltham, USA).
Transwell migration assay
Briefly, the treated cells were seeded into the transwell inserts of the upper chamber (8-μm pore size; BD Biosciences, San Jose, USA) containing serum-free DMEM, and the lower chamber was added with DMEM medium supplemented with 10% FBS, and cell proliferation was blocked by 40 μM mitoymcin C (Sigma). The transwell plates were incubated in a humidified incubator with 5% CO 2 at 37°C for 24 h. The non-migrated cells in the upper inserts were removed by a cotton swab, and the migrated cells in the bottom side were stained with crystal violet. The number of migrated cells was counted under a light microscope.
Wound healing assay
Briefly, the treated cells were cultured until 90% confluence in the 12-well plates. An area of cells was removed with a sterile pipette tip, and cell proliferation was blocked by 40 μM mitoymcin C (Sigma), and cells were further incubated for another 24 h. The wound width at 0 h and 24 h after treatments were measured. The percentage of wound closure was calculated based on the formula below: (wound width at 0 h − wound width at 24 h)/wound width at 0 h × 100%.
Western blot analysis
Proteins were extracted from VSMCs by using RIPA lysis buffer (Thermo Fisher Scientific) according to the manufacturer's instructions. The proteins were separately by electrophoresis on the SDSpolyacrylamide gel, and then transfected onto a polyvinylidene difluoride membrane. The membranes were then blocked with 1.5% skimmed milk in PBST at room temperature for 1 h. Then the membranes were incubated with primary antibodies against YY1, β-catenin or GAPDH (Abcam, Cambridge, UK) followed by incubation with corresponding horseradish peroxidase-conjugated secondary antibody. The bands were visualized using an ECL kit (Thermo Fisher Scientific) and detected by using a Bio-Rad Calibrated Densitometer (Bio-Rad, Hercules USA).
Luciferase reporter assay
For the luciferase reporter assay, cells were seeded into 12-well plates and cultured in the DMEM medium for 48 h, and then cells were co-transfected with miRNAs (mimics control, miR-147b mimics, inhibitor control, or miR-147b inhibitors) and luciferase reporter plasmids [pGL3-YY1 (wild-type)-Luc, or pGL3-YY1 (mutant)-Luc], and Renilla reporter plasmid was also transfected as an internal control. Luciferase and Renilla activity assays were analyzed at 48 h after transfection using the Lipofectamine 2000 reagent (Promega, Madison, USA). For the TOPflash luciferase assay, cells were co-transfected with TOPflash (Upstate, Lak Placid, USA) and Renilla reporter plasmid (Promega) encoding Renilla luciferase and miR-147b mimics or mimics control. Luciferase and Renilla activity assays were analyzed at 48 h after transfection using the Lipofectamine 2000 reagent (Promega). Normalized luciferase activity was defined as the ratio of luciferase activity to Renilla activity with that of control set as 1.
Statistical analysis
Data are presented as the mean ± SEM. All statistical data analysis was performed by using the Graphpad Prism Version 6.0. The significant differences among groups were analyzed by Student's t-test or one-way ANOVA. P <0.05 was considered statistically significant. 
Results
Pathogenic stimuli promoted cell proliferation and miR147b expression in VSMCs
In this study, the proliferation of VSMCs after PDGF-bb treatment was checked by CCK-8 assay in VSMCs, and PDGF-bb (20 ng/ml) enhanced the cell proliferation as indicated by the increase in OD values when compared with the negative control groups in VSMCs (Fig. 1A,B) . In addition, the expression level of miR-147b after pathogenic stimuli were determined by quantitative real-time PCR (qRT-PCR), and PDGF-bb (20 ng/ml) treatment significantly increased the expression level of miR-147b at 12, 24 and 48 h after treatment when compared with the expression level of miR-147b at 0 h post-treatment in VSMCs (Fig. 1C) . These results suggest that miR-147b may play a role in the cell proliferation of VSMCs under the pathogenic stimuli.
MiR-147b overexpression increased cell proliferation and cell migration in VSMCs
As miR-147b was up-regulated in VSMCs after pathogenic stimuli, we performed the gain-of-function assays to check the effects of miR-147b overexpression on cell proliferation and cell migration in VSMCs. The miR-147b expression levels were markedly increased after miR-147b mimics transfection in VSMCs when compared with the negative control group (Fig. 2A) . Then, the CKK-8 assay results showed that miR-147b mimics significantly increased the cell proliferation (Fig. 2B) , and the cell proliferation was shown as an increase in the number of cells from miR-147 mimics-transfected group (Fig. 2C) . Furthermore, the cell migratory potentials of VSMCs were also determined by Transwell migration assay and wound healing assay. Overexpression of miR-147b by miR-147b mimics transfection increased the number of migrated cells and accelerated the wound closure in VSMCs (Fig. 2D,E) . The results suggested that overexpression of miR-147b increased cell proliferation and cell migration in VSMCs.
MiR-147b knock-down suppressed cell proliferation and cell migration in PDGF-bb-treated VSMCs
In order to further confirm the effect of miR-147b on cell proliferation and cell migration, the loss-of-function study was also carried out in VSMCs. As expected, miR-147b knock-down by transfection with miR-147b inhibitors reduced the expression levels of miR-147b by more than 70% in VSMCs (Fig. 3A) . The knock-down of miR147b significantly suppressed cell growth and migration of VSMCs as determined by CCK-8 assay, cell number counting, transwell migration assay and wound healing assay ( Supplementary Fig. S1 ). Then, we stimulated the VSMCs with PDGF-bb first, and then transfected the VSMCs with inhibitor control or miR-147b inhibitors. As shown in Fig. 3B ,C, knock-down of miR-147b significantly suppressed cell proliferation as determined by CCK-8 assay, and the cell number was also significantly lower in miR-147b inhibitors group in comparison with control groups (Fig. 3B,C) . In addition, transfection of miR-147b inhibitors in PDGF-bb-treated VSMCs also suppressed the cell migratory potentials as revealed by the transwell migration assay and wound healing assay in comparison with control group (Fig. 3D,E) . The results implicated that knockdown of miR-147b suppressed cell proliferation and cell migration in PDGF-bb-treated VSMCs.
MiR-147b targets the 3'UTR of YY1
The potential targets of miR-147b were predicted by using the TargetScan online software, and a list of potential targets were given after prediction (Supplementary Table S1 ). In the present study, we selected YY1 for further study because YY1 is related to VSMCs proliferation. As shown in Fig. 4A , seven nucleotide bases of YY1 3′UTR were in alignment with miR-147b. Then we constructed the plasmids that expressed wild-type 3′UTR of YY1 and mutated 3′UTR of YY1, and the mutated bases were shown with bold letters in Fig. 4A . The VSMCs were then co-transfected with different miRNAs (mimics control, miR-147b mimics, inhibitor control, or miR-147b inhibitors) and vectors expressing wild-type 3′UTR of YY1 or mutated 3′UTR of YY1. The results showed that cotransfection with miR-147b mimics and vectors expressing wildtype 3′UTR of YY1 significantly suppressed the luciferase activity in VSMCs compared with control, and co-transfection with miR-147b inhibitors and vectors expressing wild-type 3′UTR of YY1 significantly increased the luciferase activity in VSMCs in comparison with control group (Fig. 4B) ; while miR-147b mimics or miR-147b inhibitors had no effect on the luciferase activity compared with control when co-transfected with mutated 3′UTR of YY1 (Fig. 4C) . In addition, it was also found that miR-147b mimics transfection significantly suppressed the mRNA and protein expression levels of YY1 compared with control group in VSMCs (Fig. 4D,E) . On the other hand, miR-147b inhibitors transfection significantly increased the mRNA and protein expression levels of YY1 compared with control group in VSMCs (Fig. 4F,G) .
YY1 suppressed the cell proliferation of VSMCs
The overexpression of YY1 was achieved by transfection with pcDNA3.1-YY1 in VSMCs, and transfection with pcDNA3.1-YY1 significantly increased the mRNA and protein expression levels of YY1 compared with control (Fig. 5A,B) . Expectedly, overexpression of YY1 significantly inhibited the cell proliferation and migration of VSMCs (Fig. 5C,D) . Consistently, knock-down of YY1 by YY1 siRNA transfection significantly increased the cell proliferation and migration of VSMCs ( Supplementary Fig. S2 ). In addition, co-transfection with miR-147b mimics and pcDNA3.1 significantly increased the cell proliferation and migration when compared with mimics control and pcDNA3.1 co-transfection group; while co-transfection with miR-147b mimics and pcDNA3.1-YY1 attenuated the effects of miR-147b mimics and pcDNA3.1 co-transfection on cell proliferation and migration of VSMCs (Fig. 5E,F) . and (E) wound healing assay (scale bar = 400 μm) determined cell migration of PDGF-bb-stimulated VSMCs after transfection with inhibitor control or miR-147b inhibitors. Data are shown as the mean ± SEM (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001 compared with control group. miR-147b and cardiovascular diseases The mRNA and (E) protein expression levels of YY1 were determined by qRT-PCR and western blot analysis, respectively, in VSMCs after transfection with mimics control or miR-147b mimics. (F) The mRNA and (G) protein expression levels of YY1 were determined by qRT-PCR and western blot analysis, respectively, in VSMCs after transfection with inhibitor control or miR-147b inhibitors. Data are shown as the mean ± SEM (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001 compared with control group.
MiR-147b enhanced the Wnt/β-catenin signaling activities
To determine whether miR-147b has an effect on the Wnt/β-catenin signaling, western blot analysis was performed to determine the protein levels of β-catenin. The overexpression of miR-147b increased the protein levels of β-catenin when compared with mimics control group (Fig. 6A) , and TOPflash assay also showed the overexpression of miR147b increased the luciferase activity when compared with the mimics control group (Fig. 6B) . Furthermore, the mRNA expression levels of the mediators involved in Wnt/β-catenin signaling were determined by qRT-PCR, and overexpression of miR-147b significantly increased the mRNA expression levels of β-catenin, c-myc and cyclin D1 and decreased mRNA expression levels of Axin and DKK1 (Fig. 6C) .
Discussion miRNAs play important roles in the regulation of gene expressions and the aberrant expression of miRNAs is associated with cardiovascular diseases [20] [21] [22] . In the present study, we demonstrated that up-regulation of miR-147b was induced by PDGF-bb treatment in VSMCs. Overexpression of miR-147b increased the cell proliferative and migratory abilities of VSMCs, while knock-down of miR147b suppressed PDGF-bb-induced cell proliferation and migration. We also observed that YY1 was a downstream target of miR-147b and up-regulation of miR-147b was accompanied with a downregulation of YY1 in VSMCs. Overexpression of YY1 suppressed cell proliferation in VSMCs and attenuated the effects of miR-147b overexpression on cell proliferation. Furthermore, overexpression of miR-147b increased the Wnt/β-catenin signaling activities in VSMCs. Aberrant proliferation of VSMCs has been found to be closely related to the arteriosclerosis development, and migration of VSMCs in the vascular wall can initiate plaque formation, which results in aggravating atherosclerosis progression [23] . PDGF-bb is one of the most potent inducers for the proliferation and migration of VSMCs, and it promotes the proliferation and migration of VSMCs via modulating key transcriptional factors and important signaling pathways including miRNA expression [24, 25] . Previously, the roles of miRNAs in regulating VSMCs proliferation and migration have been demonstrated in a handful studies. Zhang et al. [26] demonstrated that miR-29a increased cell proliferation by targeting YY1 in VSMCs. On the other hand, miR-379 was found to suppress cell proliferation and migration by interacting with insulin-growth factor-1 in VSMCs [27] , and miR-129-5p inhibited VSMC cell proliferation by targeting Wnt5a [28] . In our study, we found that upregulation of miR-147b contributed to enhanced cell proliferation and cell migration of VSMCs. In addition, VSMCs were stimulated with PGGF-bb, which induced up-regulation of miR-147b, and knock-down of miR-147b significantly suppressed cell proliferation and cell migration of VSMCs. Taken together, our results suggest that miR-147b promotes cell proliferation and migration in VSMCs.
The regulatory role of miRNAs was achieved via targeting the 3'UTR of specific genes. In the present study, we performed the (D) The cell proliferation of VSMCs was determined by CCK-8 assay after co-transfection with mimics control + pcDNA3.1, miR-147b mimics + pcDNA3.1, or miR-147b mimics + pcDNA3.1-YY1. Data are shown as the mean ± SEM (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001 compared with control group. bioinformatics prediction by using TargetScan, and found many downstream targets of miR-147b, and YY1 was chosen for further examination because YY1 was found to be associated with cell proliferation and migration in VSMCs [26] . YY1 is a ubiquitous and dual-function GLI-Kruppel zinc finger transcription factor and it has the capacity to negatively regulate the adeno-associated virus P5 promoter [17] . Luciferase reporter assay and transfection study confirmed that miR-147b regulated YY1 expression via targeting the 3′UTR of YY1, and overexpression of YY1 inhibited cell proliferation, which was in agreement with previous studies. More importantly, overexpression of YY1 attenuated the effects of miR-147b overexpression on cell proliferation of VSMCs. Apart from targeting YY1, miR-147b may also target other genes to control cell proliferation and migration of VSMCs. Further studies are needed to confirm other targets of miR-147b.
Wnt/β-catenin signaling pathway has been implicated in the regulation of cell proliferation of VSMCs [29] [30] [31] [32] [33] . Tsauousi et al. [34] showed that activation of Wnt/β-catenin signaling promoted cell proliferation of VSMCs and was associated with intimal thickening. Studies also showed that Wnt/β-catenin signaling can interact with TGF-β/Smad3 signaling to promote cell proliferation in VSMCs [35] , and hyperlipidemia induced cell proliferation involving Wnt/β-catenin in VSMCs [29] . Consistently, our results showed that miR-147b overexpression increased protein level of β-catenin in VSMCs, and also increased the TOPflash luciferase activity in VSMCs. In addition, miR-147b overexpression also modulated the mRNA expression levels of mediators involved in the Wnt/β-catenin signaling. These results suggested that miR-147b promoted cell proliferation through the enhancement of Wnt/β-catenin signaling in the VSMCs. However, further investigations are required to identify the potential mediators between miR-147b and Wnt/β-catenin signaling.
In summary, our data for the first time demonstrated the role of miR-147b in the control of cell invasion and migration of VSMCs at least via targeting YY1 and modulating the activities of Wnt/ β-catenin signaling. Our study suggested that targeting miR-147b may provide us new insights into understanding abnormal "behaviors" of VSMCs, which may be linked to the progression of cardiovascular diseases such as atherosclerosis.
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